Premium
In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies
Author(s) -
Toulon P.,
Eloit Y.,
Smahi M.,
Sigaud C.,
Jambou D.,
Fischer F.,
AppertFlory A.
Publication year - 2016
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/ijlh.12499
Subject(s) - partial thromboplastin time , thromboplastin , activated clotting time , clotting factor , tissue factor , medicine , in vitro , prothrombin time , clotting time , chemistry , pharmacology , coagulation , biochemistry , heparin
Summary Introduction Activated partial thromboplastin time ( aPTT ) is a routine clotting assay that is widely used to globally screen for coagulation abnormalities. It is commonly admitted that a prolonged test result, may trigger the need for specific assays to be performed, particularly factor measurement. However, the sensitivity of aPTT reagents to deficiencies of clotting factors varies. Methods We evaluated, according to the recommendation of the CLSI H47‐A2 guideline, the responsiveness to single factor levels of five aPTT reagents by using factor‐deficient plasmas spiked with a calibration plasma to produce individual factor activities ranging from <1 to ~100 Unit (U)/ dL . Test results were expressed as the sample‐to‐control ratio, the latter was defined as the clotting time obtained in the calibration plasma containing ~100 U/ dL factor activity. The factor activity producing a prolongation of aPTT above the upper limit of its specific normal range (in ratio) was assigned as the factor responsiveness in U/ dL to that reagent. Results Responsiveness ranged from 34 to 47 U/ dL to FVIII :C, from 18 to 57 U/ dL to FIX , from 38 to 52 U/ dL to FXI , from 29 to 50 U/ dL to FXII , from 40 and 59 U/ dL to FV , from 7.5 to 49 U/ dL to FX , and from 9.1 to 10.5 U/ dL to FII. Conclusions These results suggest that the sensitivity of the tested aPTT reagents to single factor deficiency is highly variable. Moreover, for one given aPTT reagent, its sensitivity was very different depending on the deficient factor. This must be considered when analyzing clinical materials.